ResearcherSichuan UniversityActive in the last 2 years
He Cai
Matched on ORCID iD 0000-0002-6543-3478; OpenAlex author ID A5016916625. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper
Papers 6
- Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the machine learning-based model. Co-author DOI 10.1097/js9.0000000000004008↗
- PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. Co-author DOI 10.1007/s11010-024-05078-x↗
- Perioperative risk factors for overall survival of patients with pancreatic ductal adenocarcinoma underwent laparoscopic pancreaticoduodenectomy. First author DOI 10.1007/s13304-025-02081-9↗
- Single-incision plus one port laparoscopic pancreaticoduodenectomy with major venous resection and reconstruction for pancreatic cancer (with video recordings). First author DOI 10.1016/j.asjsur.2024.05.241↗
- CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-57417-z↗
- The Effect of Age on Short- and Long-Term Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Laparoscopic Pancreaticoduodenectomy. Co-author DOI 10.1097/mpa.0000000000001620↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bing Peng · 6 shared papers, 2020–2026 · strength 1.40
- Paper Perioperative risk factors for overall survival of patients with pancreatic ductal adenocarcinoma underwent laparoscopi… DOI 10.1007/s13304-025-02081-9↗
- Paper Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the m… DOI 10.1097/js9.0000000000004008↗
- Paper Single-incision plus one port laparoscopic pancreaticoduodenectomy with major venous resection and reconstruction for p… DOI 10.1016/j.asjsur.2024.05.241↗
- Xin Wang · 3 shared papers, 2024–2026 · strength 0.70
- Paper Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the m… DOI 10.1097/js9.0000000000004008↗
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- Ke Cheng · 2 shared papers, 2024–2025 · strength 0.42
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- Qiangxing Chen · 2 shared papers, 2024–2025 · strength 0.42
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- Jing Zhang · 1 shared paper, 2025 · strength 0.33
- Tianrui Kuang · 1 shared paper, 2026 · strength 0.28
- Zhong Wu · 1 shared paper, 2026 · strength 0.28
- Yu Cai · 1 shared paper, 2024 · strength 0.26
- Xin Wang · 1 shared paper, 2020 · strength 0.12
- Lingwei Meng · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.